BDBM557764 (1S,3′R,6′R,7′S,11′S,12′R)-6-CHLORO-11′,12′-DIMETHYL-7′-(CIS-5-(2-OXA-6-AZASPIRO[3.3]HEPT-6-YL)-1,3-DIOXAN-2-YL)-3,4-DIHYDRO-2H,15′H-SPIRO[NAPHTHALENE-1,22′-[20]OXA[13]THIA[1,14]DIAZATETRACYCLO[14.7.2.0˜3,6˜.0˜19,24˜]PENTACOSA[16,18,24]TRIEN]-15′-ONE 13′,13′-DIOXIDE::US11364248, Example 59
SMILES C[C@H]1CCC[C@@H]([C@@H]2CC[C@H]2CN2C[C@@]3(CCCc4cc(Cl)ccc34)COc3ccc(cc23)C(=O)NS(=O)(=O)[C@@H]1C)[C@@H]1OC[C@@H](CO1)N1CC2(COC2)C1
InChI Key InChIKey=LJSDZNCKKNDWCD-UXUNTCLLSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 557764
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Amgen
US Patent
Amgen
US Patent
Affinity DataIC50: 0.319nMAssay Description:The inhibition of the Mcl-1/Bim interaction was measured using a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. The recombinan...More data for this Ligand-Target Pair